1. Home
  2. SLRC vs DNA Comparison

SLRC vs DNA Comparison

Compare SLRC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRC
  • DNA
  • Stock Information
  • Founded
  • SLRC 2007
  • DNA 2008
  • Country
  • SLRC United States
  • DNA United States
  • Employees
  • SLRC N/A
  • DNA N/A
  • Industry
  • SLRC Finance/Investors Services
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SLRC Finance
  • DNA Health Care
  • Exchange
  • SLRC Nasdaq
  • DNA Nasdaq
  • Market Cap
  • SLRC 771.9M
  • DNA 895.1M
  • IPO Year
  • SLRC 2010
  • DNA N/A
  • Fundamental
  • Price
  • SLRC $15.46
  • DNA $12.70
  • Analyst Decision
  • SLRC Hold
  • DNA Strong Sell
  • Analyst Count
  • SLRC 6
  • DNA 1
  • Target Price
  • SLRC $15.96
  • DNA $9.00
  • AVG Volume (30 Days)
  • SLRC 339.6K
  • DNA 1.7M
  • Earning Date
  • SLRC 11-04-2025
  • DNA 11-07-2025
  • Dividend Yield
  • SLRC 10.72%
  • DNA N/A
  • EPS Growth
  • SLRC N/A
  • DNA N/A
  • EPS
  • SLRC 1.63
  • DNA N/A
  • Revenue
  • SLRC $222,445,000.00
  • DNA $230,815,000.00
  • Revenue This Year
  • SLRC N/A
  • DNA N/A
  • Revenue Next Year
  • SLRC $0.23
  • DNA $14.41
  • P/E Ratio
  • SLRC $9.51
  • DNA N/A
  • Revenue Growth
  • SLRC N/A
  • DNA 25.21
  • 52 Week Low
  • SLRC $13.64
  • DNA $5.00
  • 52 Week High
  • SLRC $17.94
  • DNA $17.58
  • Technical
  • Relative Strength Index (RSI)
  • SLRC 59.30
  • DNA 45.99
  • Support Level
  • SLRC $13.95
  • DNA $12.65
  • Resistance Level
  • SLRC $15.59
  • DNA $13.77
  • Average True Range (ATR)
  • SLRC 0.27
  • DNA 1.10
  • MACD
  • SLRC 0.19
  • DNA -0.25
  • Stochastic Oscillator
  • SLRC 90.85
  • DNA 15.77

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: